Chapter 65 Clinical Trials (More Updates Please Read!)
In America, once entrepreneurs achieve a certain level of success, they will try every means to exert their influence in Washington, and even the Internet upstarts in Silicon Valley are no exception.
Chen Yuanguang learned this truth through virtual reality, and also realized that virtual reality games are a treasure trove. Many things can be practiced through it, providing reference opinions for similar situations in the future.
If he wants to change the world according to his own will and live up to the golden finger he has obtained, then the prerequisite is to have a strong enough influence. He finds that controlling the country is a better way than starting a business.
In modern society, to achieve this goal, nothing is more important than mastering information security technology.
Data means everything. When you have data, you will have more intelligence to support your decision-making and can make more accurate judgments.
Chen Yuanguang is studying information security technology and computer technology hard in the future, and he is a programmer.
Chen Yuanguang thought, fortunately he chose network security when downloading knowledge before, so he had a certain foundation. Now he needed to improve and put it into practice in modern time and space.
Chen Yuanguang found a solution in the future time and space, and in modern time and space he plans to continue to advance the research on human hibernation technology. Controlling a country, even a small country in Southeast Asia, requires long-term planning.
The nth clinical trial:
"Dr. Song, what is the data on human hibernation?"
"From the data, it can be seen that the human body's hibernation signs were induced, and the brain waves also showed signs of hibernation, but he was still awake, which was completely different from the state shown by the experimental monkeys."
After the researchers of Guangjia Technology were poached and then sued, a new group of researchers have been replaced. After this group of people came in, they signed a stricter confidentiality agreement and were given option incentives to increase the cost of breach of contract for the other party.
The penalty for breach of contract is directly proportional to the salary you give him. The higher the salary you pay him, the more penalty for breach of contract he will have to bear.
You pay someone a salary of 3,500 yuan, and then he resigns and changes jobs. You expect him to compensate you with 200,000 yuan. This is unrealistic. The rights and obligations are completely unequal.
Every failure makes one wiser. Now Guangjia Technology provides equity incentives for its core R&D personnel, but they have to wait until the company goes public to realize the cash.
However, according to the valuation of the angel round of financing, it is also a considerable amount. If these people resign, the corresponding liquidated damages will be enough to empty the houses of most of them.
Since entering 2022, the virus has been brought under control worldwide through broad-spectrum vaccines. Except for a few underdeveloped areas where the virus is still prevalent, other places have been fully relaxed.
"The 2022 Nobel Prize in Physiology or Medicine was finally awarded to Professors Katrin Kouriko and Drew Weisman. In appreciation of their groundbreaking discoveries in the field of mRNA, Dr. Chen Yuanguang, a Chinese scientist who was previously considered a favorite for this year's Nobel Prize in Physiology or Medicine, unfortunately missed out on this year's Nobel Prize.
However, most people in the academic community believe that Dr. Chen Yuanguang will sooner or later make greater scientific achievements and win the Nobel Prize in Physiology, or win the Nobel Prize in Physiology in the future through his outstanding contribution to the virus mutation prediction model. "
At this time, Chen Yuanguang had already passed the remote defense and received the doctorate degree awarded by MIT. Therefore, there was no problem at all in calling him Dr. Chen Yuanguang.
"How do you evaluate the fact that the 2022 Nobel Prize in Physiology was not awarded to Guangshen?" "It's a pity. The solution to the virus was a major event this year. Anyone with a discerning eye can see that the biggest contributor was Guangshen's virus prediction model, which made the broad-spectrum vaccine a reality. But it's not wrong to award it to Katrin and Drew. After all, the underlying basis of the broad-spectrum vaccine is also the mRNA vaccine, and the two of them discovered the feasibility of the mRNA vaccine.
It's a pity, Guang Shen is so young, I thought he could continue to create miracles. In addition, I think Guang Shen should be very close, but the judges thought he was too young, plus he is Chinese, so he was a little short.
Sometimes I wonder if Guangshen joined the Gates Foundation and let the Gates Foundation help him run the project, would he have won? The Gates Foundation has a great influence in the academic world. In addition, Guangshen has disappeared from the academic world since he published his graduation thesis at the end of 21. Everyone knows that he went to the industry to start a business in human hibernation technology. It is also possible that he has not been heard for too long, so the judges with voting rights did not choose him.
In short, if it were me, I would first negotiate with the Gates Foundation, I would join you, you would help me run the Nobel Prize, and then start a business after I got the Nobel Prize. And I feel that the direction of Guangshen's entrepreneurship is also an unpopular one among unpopular ones.
The technology itself is not unpopular in the eyes of the public, and human hibernation has been mentioned in various science fiction works. The problem is that in academia, this direction is very unpopular. Ever since the two major powers invested a lot of manpower and material resources during the Cold War and failed to develop it, this direction has become an unpopular direction.
Last year, the media hyped it up, but now we haven’t seen any concrete results. The direction chosen by Guangshen is still too difficult.”
"He was already famous in the academic world, and had published countless papers in Nature and Science. His future was bright, but he went to work on human hibernation technology. How foolish!"
"I am quite optimistic. If Guang Shen can develop human hibernation technology, he will still get the Nobel Prize."
"There is an answer under this question saying that if the God of Light can develop human hibernation technology, he will be awarded the Nobel Prize. The question is, is human hibernation technology that easy to develop? There was a lot of publicity last year, with the New York Times, CNN, and Fox taking turns to support it, but now there is nothing at all, right?"
"It seems that the God of Light has recently established another company, also called Light Armor. It seems to be Light Armor Aerospace Technology Co., Ltd., but I don't know what it does specifically."
"I became famous at a young age. I wanted to do too many things when I became famous too early. The result is that I wanted everything but nothing happened."
"If you ask me, it's because everyone expects too much from him, as if publishing two CNS papers a year is normal. What Guangshen needs is to settle down and accumulate knowledge before making a breakthrough."
In the answers to the question about Chen Yuanguang not winning the Nobel Prize on Zhihu, most people expressed regret and believed that he had chosen the wrong direction.
Before playing virtual reality games, Chen Yuanguang himself might have felt disappointed for not winning an award, but now he knows that no matter how well-packaged or awesome something like an award is, it can still work.
Unless you produce results that leave everyone speechless, others will always have reasons not to give it to you.
After Chen Yuanguang became indifferent, he no longer cared too much about it. And what was said on Zhihu was correct. He established another aerospace technology company and invested all the profits from the settlement of Past Events in Kuala Lumpur 2 into it, with a paid-in capital of 7 million.
He is in charge of both companies, and the first clinical trial of human hibernation is about to begin, so he really has no time to care about these things.
(End of this chapter)